ENVUE MEDICAL INC (FEED) Fundamental Analysis & Valuation
NASDAQ:FEED • US63008J8844
Current stock price
1.96 USD
-0.11 (-5.31%)
At close:
1.65 USD
-0.31 (-15.82%)
After Hours:
This FEED fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. FEED Profitability Analysis
1.1 Basic Checks
- In the past year FEED has reported negative net income.
- In the past year FEED has reported a negative cash flow from operations.
- FEED had negative earnings in each of the past 5 years.
- FEED had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- FEED has a better Return On Assets (-10.54%) than 60.11% of its industry peers.
- FEED's Return On Equity of -13.40% is fine compared to the rest of the industry. FEED outperforms 66.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.54% | ||
| ROE | -13.4% | ||
| ROIC | N/A |
ROA(3y)-83.46%
ROA(5y)-93.73%
ROE(3y)-284.16%
ROE(5y)-251.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- FEED has a Gross Margin of 32.06%. This is in the lower half of the industry: FEED underperforms 73.94% of its industry peers.
- In the last couple of years the Gross Margin of FEED has grown nicely.
- The Profit Margin and Operating Margin are not available for FEED so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.07% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.18%
GM growth 5Y2.22%
2. FEED Health Analysis
2.1 Basic Checks
- FEED does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, FEED has more shares outstanding
- FEED has less shares outstanding than it did 5 years ago.
- FEED has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -2.42, we must say that FEED is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of FEED (-2.42) is worse than 64.89% of its industry peers.
- A Debt/Equity ratio of 0.05 indicates that FEED is not too dependend on debt financing.
- FEED's Debt to Equity ratio of 0.05 is fine compared to the rest of the industry. FEED outperforms 69.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.42 |
ROIC/WACCN/A
WACC10.52%
2.3 Liquidity
- FEED has a Current Ratio of 1.05. This is a normal value and indicates that FEED is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of FEED (1.05) is worse than 87.23% of its industry peers.
- A Quick Ratio of 0.72 indicates that FEED may have some problems paying its short term obligations.
- With a Quick ratio value of 0.72, FEED is not doing good in the industry: 86.70% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.72 |
3. FEED Growth Analysis
3.1 Past
- FEED shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.29%.
- Looking at the last year, FEED shows a very negative growth in Revenue. The Revenue has decreased by -18.41% in the last year.
- Measured over the past years, FEED shows a very strong growth in Revenue. The Revenue has been growing by 37.00% on average per year.
EPS 1Y (TTM)-25.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.68%
Revenue 1Y (TTM)-18.41%
Revenue growth 3Y14.59%
Revenue growth 5Y37%
Sales Q2Q%92.02%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. FEED Valuation Analysis
4.1 Price/Earnings Ratio
- FEED reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. FEED Dividend Analysis
5.1 Amount
- FEED does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FEED Fundamentals: All Metrics, Ratios and Statistics
1.96
-0.11 (-5.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-30 2026-03-30
Earnings (Next)05-18 2026-05-18
Inst Owners2.57%
Inst Owner Change0%
Ins Owners22.06%
Ins Owner Change0%
Market Cap2.14M
Revenue(TTM)2.69M
Net Income(TTM)-5.42M
Analysts82.86
Price TargetN/A
Short Float %10.56%
Short Ratio0.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.91 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-83.93
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.61
FCFYN/A
OCF(TTM)-5.61
OCFYN/A
SpS2.15
BVpS37.13
TBVpS-3.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.54% | ||
| ROE | -13.4% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.07% | ||
| FCFM | N/A |
ROA(3y)-83.46%
ROA(5y)-93.73%
ROE(3y)-284.16%
ROE(5y)-251.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.18%
GM growth 5Y2.22%
F-Score2
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 2.36% | ||
| Cap/Sales | 0.38% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | -2.42 |
F-Score2
WACC10.52%
ROIC/WACCN/A
Cap/Depr(3y)233.33%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.19%
Cap/Sales(5y)0.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.41%
Revenue growth 3Y14.59%
Revenue growth 5Y37%
Sales Q2Q%92.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-212.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.63%
OCF growth 3YN/A
OCF growth 5YN/A
ENVUE MEDICAL INC / FEED Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ENVUE MEDICAL INC?
ChartMill assigns a fundamental rating of 2 / 10 to FEED.
What is the valuation status for FEED stock?
ChartMill assigns a valuation rating of 0 / 10 to ENVUE MEDICAL INC (FEED). This can be considered as Overvalued.
Can you provide the profitability details for ENVUE MEDICAL INC?
ENVUE MEDICAL INC (FEED) has a profitability rating of 2 / 10.
Can you provide the financial health for FEED stock?
The financial health rating of ENVUE MEDICAL INC (FEED) is 2 / 10.